Sun Mo Nam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sun Mo Nam has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Chul-Kee Park
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
11 shared publications - Jong Ha Hwang
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
7 shared publications - Min-Sung Kim
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
7 shared publications - Yong Hwy Kim
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
7 shared publications - Yoon Hwan Byun
Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
6 shared publications - Hye Seok Park
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
4 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Springer Nature in Scientific Reports
Prediction of postoperative intracerebral hemorrhage following brain biopsy using integrated statistical and machine learning analyses
- 4 September 2026
- Published by Springer Nature in Scientific Reports
Open AccessPrediction of postoperative intracerebral hemorrhage following brain biopsy using integrated statistical and machine learning analyses
- Open Access
- 16 June 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (4) , 100
The Limited Role of Hypocortisolism in the Development of Delayed Postoperative Hyponatremia After Pituitary Surgery
Purpose: Delayed postoperative hyponatremia (DPH) is a common complication following pituitary surgery. Although hypocortisolism has been proposed as a contributing factor, the temporal interplay between cortisol and sodium levels remains unclear. This study aimed to elucidate the relationship between postoperative cortisol and sodium dynamics, identify independent predictors of DPH and assess potential protective factors. Methods: We retrospectively analyzed 261 patients who underwent fully endoscopic surgery for clinically non-functioning pituitary neuroendocrine tumors (Pit-NETs, also known as pituitary adenomas) between 2021 and 2024. Serial measurements of serum sodium and morning cortisol were collected from the immediate postoperative period through 3-month follow-up. Comparative analyses between patients with and without DPH were performed to characterize hormonal and electrolyte trends. The frequency of hypocortisolism during hyponatremic episodes was compared, and multivariable logistic regression identified independent predictors. The potential protective role of preoperative steroid replacement was also evaluated. Results: DPH occurred in 54 patients (20.7%), with symptomatic cases accounting for 4.2% of the cohort. The median time to nadir sodium was 8 days with a median nadir of 129 mEq/L. The serum cortisol level between hyponatremia and non-hyponatremia group did not show significant differences. For propensity score matched comparison, median nadir cortisol levels were lower in the DPH group (6.10 vs. 7.34 µg/dL, p = 0.29), and hypocortisolism during hyponatremic episodes was more frequent (48.2% vs. 40.7%, p = 0.52), though neither difference reached statistical significance. Multivariate analysis identified age > 60 years (OR 2.09, 95% CI 1.11–3.96, p = 0.023) and postoperative pneumocephalus (OR 3.28, 95% CI 1.59–6.81, p = 0.001) as independent predictors. Preoperative cortisol replacement did not demonstrate a protective effect against DPH. Conclusion: Hypocortisolism does not appear to be the primary mechanism underlying DPH following pituitary surgery, as evidenced by the lack of temporal correlation. Advanced age and postoperative pneumocephalus emerge as key risk factors for DPH, supporting a multifactorial etiology. Although preoperative ACTH deficiency was linked to a higher incidence of DPH, preoperative cortisol replacement was not associated with protection.
- 16 June 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (4) , 100
Open AccessThe Limited Role of Hypocortisolism in the Development of Delayed Postoperative Hyponatremia After Pituitary Surgery
Purpose: Delayed postoperative hyponatremia (DPH) is a common complication following pituitary surgery. Although hypocortisolism has been proposed as a contributing factor, the temporal interplay between cortisol and sodium levels remains unclear. This study aimed to elucidate the relationship between postoperative cortisol and sodium dynamics, identify independent predictors of DPH and assess potential protective factors. Methods: We retrospectively analyzed 261 patients who underwent fully endoscopic surgery for clinically non-functioning pituitary neuroendocrine tumors (Pit-NETs, also known as pituitary adenomas) between 2021 and 2024. Serial measurements of serum sodium and morning cortisol were collected from the immediate postoperative period through 3-month follow-up. Comparative analyses between patients with and without DPH were performed to characterize hormonal and electrolyte trends. The frequency of hypocortisolism during hyponatremic episodes was compared, and multivariable logistic regression identified independent predictors. The potential protective role of preoperative steroid replacement was also evaluated. Results: DPH occurred in 54 patients (20.7%), with symptomatic cases accounting for 4.2% of the cohort. The median time to nadir sodium was 8 days with a median nadir of 129 mEq/L. The serum cortisol level between hyponatremia and non-hyponatremia group did not show significant differences. For propensity score matched comparison, median nadir cortisol levels were lower in the DPH group (6.10 vs. 7.34 µg/dL, p = 0.29), and hypocortisolism during hyponatremic episodes was more frequent (48.2% vs. 40.7%, p = 0.52), though neither difference reached statistical significance. Multivariate analysis identified age > 60 years (OR 2.09, 95% CI 1.11–3.96, p = 0.023) and postoperative pneumocephalus (OR 3.28, 95% CI 1.59–6.81, p = 0.001) as independent predictors. Preoperative cortisol replacement did not demonstrate a protective effect against DPH. Conclusion: Hypocortisolism does not appear to be the primary mechanism underlying DPH following pituitary surgery, as evidenced by the lack of temporal correlation. Advanced age and postoperative pneumocephalus emerge as key risk factors for DPH, supporting a multifactorial etiology. Although preoperative ACTH deficiency was linked to a higher incidence of DPH, preoperative cortisol replacement was not associated with protection.
- Open Access
- 1 May 2026
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 69 (3) , 472-481
Early Clinical Experience with the Stealth Autoguide Cranial Robotic Guidance Platform for Stereotactic Brain Biopsy
Objective : The aim of this study was to report the early clinical experience with stereotactic biopsy using the Medtronic Stealth Autoguide Cranial Robotic Guidance Platform, representing the first relevant clinical study in the Republic of Korea (ROK). We evaluated potential advantages and limitations related to workflow integration, instrument setup, procedural efficiency, accuracy, and safety.Methods : A retrospective case series was conducted across three centers in the ROK. From April to July 2025, 17 consecutive patients underwent frameless stereotactic biopsy using the Stealth Autoguide system. Data on demographics, operative time, and complications were collected, and descriptive analyses were performed.Results : Biopsy using the Stealth Autoguide System was successfully completed in 16 of 17 patients. The median operative time was 48 minutes (interquartile range, 33–64), and the median target alignment error was 0.4 mm (interquartile range, 0.3–0.6). One case required conversion to the conventional manual method due to targeting inaccuracy. Three cases of asymptomatic intracerebral hemorrhage occurred, including one at the tissue-harvest site and two with cortical hemorrhage, all of which were managed conservatively.Conclusion : The Stealth Autoguide system facilitates a more efficient frameless stereotactic biopsy than conventional methods by reducing operative time, enhancing accuracy, and allowing for a smaller, muscle-sparing incision. However, some concerns remain, and further clinical validation is needed to define its optimal indications and safety profile.
- 1 May 2026
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 69 (3) , 472-481
Open AccessEarly Clinical Experience with the Stealth Autoguide Cranial Robotic Guidance Platform for Stereotactic Brain Biopsy
Objective : The aim of this study was to report the early clinical experience with stereotactic biopsy using the Medtronic Stealth Autoguide Cranial Robotic Guidance Platform, representing the first relevant clinical study in the Republic of Korea (ROK). We evaluated potential advantages and limitations related to workflow integration, instrument setup, procedural efficiency, accuracy, and safety.Methods : A retrospective case series was conducted across three centers in the ROK. From April to July 2025, 17 consecutive patients underwent frameless stereotactic biopsy using the Stealth Autoguide system. Data on demographics, operative time, and complications were collected, and descriptive analyses were performed.Results : Biopsy using the Stealth Autoguide System was successfully completed in 16 of 17 patients. The median operative time was 48 minutes (interquartile range, 33–64), and the median target alignment error was 0.4 mm (interquartile range, 0.3–0.6). One case required conversion to the conventional manual method due to targeting inaccuracy. Three cases of asymptomatic intracerebral hemorrhage occurred, including one at the tissue-harvest site and two with cortical hemorrhage, all of which were managed conservatively.Conclusion : The Stealth Autoguide system facilitates a more efficient frameless stereotactic biopsy than conventional methods by reducing operative time, enhancing accuracy, and allowing for a smaller, muscle-sparing incision. However, some concerns remain, and further clinical validation is needed to define its optimal indications and safety profile.
- Open Access
- 23 February 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (8)
Real-time intraoperative confocal laser endomicroscopy with on-site neuropathologist consultation for glioma margin assessment: illustrative case
BACKGROUND: Achieving maximal safe resection in glioma surgery requires accurate real-time margin assessment, yet existing technologies have limitations. Fluorescence-guided surgery shows limitations at infiltrative margins, while frozen section analysis requires 20–45 minutes per specimen. Confocal laser endomicroscopy (CLE) is an emerging in vivo imaging technology that enables real-time cellular-resolution tissue examination in situ. OBSERVATIONS: The authors present a case demonstrating integration of CLE with on-site neuropathologist collaboration for real-time intraoperative diagnosis. A 53-year-old woman with left frontotemporal high-grade glioma underwent surgery with systematic examination of five locations using CLE. The collaborative workflow enabled rapid tissue assessment (mean 95 seconds per site) with immediate expert interpretation. Critically, high-grade glioma was detected at a site with complete absence of 5-aminolevulinic acid fluorescence (spot 4), demonstrating CLE’s capability to identify tumor infiltration beyond fluorescence-guided boundaries and enabling extended resection. LESSONS: Integrating CLE with on-site pathologist consultation creates an effective paradigm for real-time margin assessment, addressing the 30%–40% false-negative rate of fluorescence guidance. This collaborative approach is immediately implementable at centers with neuropathology expertise and establishes a foundation for future telepathology and artificial intelligence–assisted diagnostic platforms. https://thejns.org/doi/10.3171/CASE25890
- 23 February 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (8)
Open AccessReal-time intraoperative confocal laser endomicroscopy with on-site neuropathologist consultation for glioma margin assessment: illustrative case
BACKGROUND: Achieving maximal safe resection in glioma surgery requires accurate real-time margin assessment, yet existing technologies have limitations. Fluorescence-guided surgery shows limitations at infiltrative margins, while frozen section analysis requires 20–45 minutes per specimen. Confocal laser endomicroscopy (CLE) is an emerging in vivo imaging technology that enables real-time cellular-resolution tissue examination in situ. OBSERVATIONS: The authors present a case demonstrating integration of CLE with on-site neuropathologist collaboration for real-time intraoperative diagnosis. A 53-year-old woman with left frontotemporal high-grade glioma underwent surgery with systematic examination of five locations using CLE. The collaborative workflow enabled rapid tissue assessment (mean 95 seconds per site) with immediate expert interpretation. Critically, high-grade glioma was detected at a site with complete absence of 5-aminolevulinic acid fluorescence (spot 4), demonstrating CLE’s capability to identify tumor infiltration beyond fluorescence-guided boundaries and enabling extended resection. LESSONS: Integrating CLE with on-site pathologist consultation creates an effective paradigm for real-time margin assessment, addressing the 30%–40% false-negative rate of fluorescence guidance. This collaborative approach is immediately implementable at centers with neuropathology expertise and establishes a foundation for future telepathology and artificial intelligence–assisted diagnostic platforms. https://thejns.org/doi/10.3171/CASE25890
- Open Access
- 12 February 2026
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
Surgical outcomes of endoscopic endonasal surgery for nonfunctioning pituitary adenoma in elderly patients: a comprehensive analysis beyond age
Background: Due to the rapid aging of the global population, it is challenging to identify elderly individuals who are optimal candidates for the surgical treatment of pituitary neuroendocrine tumors. While chronological age has traditionally influenced surgical decision-making, the independent effect of age on outcomes requires a comprehensive evaluation that controls for comorbidities and tumor characteristics. Methods: This retrospective analysis included 305 patients (≥18 years) who underwent endoscopic endonasal surgery for clinically nonfunctioning pituitary neuroendocrine tumors between March 2020 and February 2024 at a single tertiary center. Patients were stratified by age (<65 vs. ≥65 years) and evaluated using propensity score matching. The outcomes included gross total resection rates, complications, endocrinological recovery, and visual outcomes. Composite outcome measures were developed to assess multifaceted surgical success. Maximally selected rank statistics identified optimal age cutoffs for hormone recovery. Results: The cohort included 305 patients. Elderly patients (≥65 years, n=105) presented with significantly greater comorbidity burdens, including hypertension and diabetes. Following propensity score matching (n=105 per group), no significant age-based differences were observed in terms of gross total resection rates (84.8% vs. 84.8%) or major complications. Age 57 was found to be the optimal cutoff for endocrinological recovery (60.7% vs. 33.1%, p<0.001), with the gonadotroph axis being the most significantly affected hormone axis. The visual outcomes demonstrated remarkable age independence, as recovery was mainly dependent on gross total resection and preoperative visual field severity. Multivariate analysis demonstrated that higher body mass index (BMI), specific cardiovascular comorbidities, and intraoperative cerebrospinal fluid leaks, rather than chronological age, served as independent predictors of adverse outcomes, including surgical site infections and prolonged hospital stays. Conclusion: Chronological age alone should not constitute an absolute contraindication to endoscopic pituitary surgery. These findings underscore that comprehensive preoperative evaluations should prioritize functional status and modifiable risk factors, including cardiovascular comorbidities and BMI, to optimize outcomes for patients of all ages.
- 12 February 2026
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 26 (1)
Open AccessSurgical outcomes of endoscopic endonasal surgery for nonfunctioning pituitary adenoma in elderly patients: a comprehensive analysis beyond age
Background: Due to the rapid aging of the global population, it is challenging to identify elderly individuals who are optimal candidates for the surgical treatment of pituitary neuroendocrine tumors. While chronological age has traditionally influenced surgical decision-making, the independent effect of age on outcomes requires a comprehensive evaluation that controls for comorbidities and tumor characteristics. Methods: This retrospective analysis included 305 patients (≥18 years) who underwent endoscopic endonasal surgery for clinically nonfunctioning pituitary neuroendocrine tumors between March 2020 and February 2024 at a single tertiary center. Patients were stratified by age (<65 vs. ≥65 years) and evaluated using propensity score matching. The outcomes included gross total resection rates, complications, endocrinological recovery, and visual outcomes. Composite outcome measures were developed to assess multifaceted surgical success. Maximally selected rank statistics identified optimal age cutoffs for hormone recovery. Results: The cohort included 305 patients. Elderly patients (≥65 years, n=105) presented with significantly greater comorbidity burdens, including hypertension and diabetes. Following propensity score matching (n=105 per group), no significant age-based differences were observed in terms of gross total resection rates (84.8% vs. 84.8%) or major complications. Age 57 was found to be the optimal cutoff for endocrinological recovery (60.7% vs. 33.1%, p<0.001), with the gonadotroph axis being the most significantly affected hormone axis. The visual outcomes demonstrated remarkable age independence, as recovery was mainly dependent on gross total resection and preoperative visual field severity. Multivariate analysis demonstrated that higher body mass index (BMI), specific cardiovascular comorbidities, and intraoperative cerebrospinal fluid leaks, rather than chronological age, served as independent predictors of adverse outcomes, including surgical site infections and prolonged hospital stays. Conclusion: Chronological age alone should not constitute an absolute contraindication to endoscopic pituitary surgery. These findings underscore that comprehensive preoperative evaluations should prioritize functional status and modifiable risk factors, including cardiovascular comorbidities and BMI, to optimize outcomes for patients of all ages.
- 19 January 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (1) , 32
Clinical characteristics and risk factors of delayed ophthalmoplegia following cavernous sinus exploration in endoscopic pituitary adenoma surgery
Purpose Postoperative cranial nerve dysfunction remains a significant concern in endoscopic endonasal surgery for pituitary neuroendocrine tumors (PitNETs, also known as pituitary adenomas) that have invaded the cavernous sinus, but the incidence, timing, and recovery patterns vary widely across reports. This study aimed to characterize the clinical features, risk factors, and recovery patterns of patients with postoperative ophthalmoplegia following cavernous sinus exploration. Methods We retrospectively analyzed 127 consecutive patients who underwent endoscopic skull base surgery with cavernous sinus exploration between March 2020 and September 2024. Ophthalmoplegia onset, affected cranial nerves, and prognosis were evaluated. Risk factors were assessed using multivariable logistic regression, and recovery patterns were analyzed using Kaplan‒Meier curves. Results The overall gross total resection rate was 74.8% (96.9% for functioning adenomas), with 96.9% biochemical remission in functioning PitNETs at 3-month follow-up. New cranial nerve dysfunction occurred in 13.6% (17/125), manifesting exclusively as ophthalmoplegia. The abducen nerve was most frequently affected nerve (52.9%), followed by the oculomotor (41.2%) and trochlear nerves (11.8%). Early onset (≤ 3 days) occurred in 29.4%, while delayed onset (> 3 days) occurred in 70.6% of cases (mean onset: 9 days). Extensive hemostatic agent use (≥ 3 applications) (OR 15.57, p < 0.001) and lateral compartment involvement (OR 9.00, p = 0.011) were significant risk factors. Complete resolution occurred in 94.1% with median duration of 20 days. Conclusions Postoperative ophthalmoplegia following cavernous sinus exploration occurs more frequently than previously reported but follows a benign course with near-complete resolution. The distinct temporal patterns and risk factors suggest different pathophysiological mechanisms for early- versus delayed-onset ophthalmoplegia, guiding surgical decisions and patient counseling.
- 19 January 2026
- Published by Springer Nature in Pituitary
- Vol. 29 (1) , 32
Clinical characteristics and risk factors of delayed ophthalmoplegia following cavernous sinus exploration in endoscopic pituitary adenoma surgery
Purpose Postoperative cranial nerve dysfunction remains a significant concern in endoscopic endonasal surgery for pituitary neuroendocrine tumors (PitNETs, also known as pituitary adenomas) that have invaded the cavernous sinus, but the incidence, timing, and recovery patterns vary widely across reports. This study aimed to characterize the clinical features, risk factors, and recovery patterns of patients with postoperative ophthalmoplegia following cavernous sinus exploration. Methods We retrospectively analyzed 127 consecutive patients who underwent endoscopic skull base surgery with cavernous sinus exploration between March 2020 and September 2024. Ophthalmoplegia onset, affected cranial nerves, and prognosis were evaluated. Risk factors were assessed using multivariable logistic regression, and recovery patterns were analyzed using Kaplan‒Meier curves. Results The overall gross total resection rate was 74.8% (96.9% for functioning adenomas), with 96.9% biochemical remission in functioning PitNETs at 3-month follow-up. New cranial nerve dysfunction occurred in 13.6% (17/125), manifesting exclusively as ophthalmoplegia. The abducen nerve was most frequently affected nerve (52.9%), followed by the oculomotor (41.2%) and trochlear nerves (11.8%). Early onset (≤ 3 days) occurred in 29.4%, while delayed onset (> 3 days) occurred in 70.6% of cases (mean onset: 9 days). Extensive hemostatic agent use (≥ 3 applications) (OR 15.57, p < 0.001) and lateral compartment involvement (OR 9.00, p = 0.011) were significant risk factors. Complete resolution occurred in 94.1% with median duration of 20 days. Conclusions Postoperative ophthalmoplegia following cavernous sinus exploration occurs more frequently than previously reported but follows a benign course with near-complete resolution. The distinct temporal patterns and risk factors suggest different pathophysiological mechanisms for early- versus delayed-onset ophthalmoplegia, guiding surgical decisions and patient counseling.
- Open Access
- 1 December 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 303
Histopathologic risk factors for progression of atypical meningioma: a retrospective cohort study evaluating the impact and clinical value of mitotic count and Ki-67
Purpose: Given the heterogeneity of atypical meningioma (AM) and potential interobserver variability in WHO grade assignment among pathologists, there is a need for more objective criteria to improve risk stratification. This study examined conventional and novel risk factors for AM progression, focusing on mitotic count (MC) and Ki-67, and explored their clinical relevance. Methods: This retrospective cohort study included 240 consecutive patients with AM surgically treated at a single tertiary institution between 2001 and 2020. The cut-off values for MC and Ki-67 were determined using the Youden index. Risk factors for progression were analyzed using cause-specific Cox proportional hazards models. Progression-free survival (PFS) was estimated using cumulative incidence function (CIF) and compared using the Gray’s test. Results: AM progression occurred in 32.5% of patients with a median time to progression of 25.2 months. The median follow-up was 42.3 months. While a clinically meaningful Ki-67 cut-off was not identified, MC ≥ 6 was significantly associated with AM progression. On multivariate analysis, age, gross total resection (GTR), MC ≥ 6, brain invasion, sheeting, and adjuvant radiotherapy (RTx) were associated with progression. RTx improved PFS in the subtotal resection (STR) group but not in the GTR group. Among GTR patients, those with MC ≥ 6 had worse outcomes. Conclusion: GTR and RTx may reduce the progression of AM. MC ≥ 6 significantly increases the risk of progression, even in GTR patients. RTx should be considered for all STR patients A more vigilant follow-up or consideration of RTx is warranted in GTR patients when a high MC is identified.
- 1 December 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 303
Open AccessHistopathologic risk factors for progression of atypical meningioma: a retrospective cohort study evaluating the impact and clinical value of mitotic count and Ki-67
Purpose: Given the heterogeneity of atypical meningioma (AM) and potential interobserver variability in WHO grade assignment among pathologists, there is a need for more objective criteria to improve risk stratification. This study examined conventional and novel risk factors for AM progression, focusing on mitotic count (MC) and Ki-67, and explored their clinical relevance. Methods: This retrospective cohort study included 240 consecutive patients with AM surgically treated at a single tertiary institution between 2001 and 2020. The cut-off values for MC and Ki-67 were determined using the Youden index. Risk factors for progression were analyzed using cause-specific Cox proportional hazards models. Progression-free survival (PFS) was estimated using cumulative incidence function (CIF) and compared using the Gray’s test. Results: AM progression occurred in 32.5% of patients with a median time to progression of 25.2 months. The median follow-up was 42.3 months. While a clinically meaningful Ki-67 cut-off was not identified, MC ≥ 6 was significantly associated with AM progression. On multivariate analysis, age, gross total resection (GTR), MC ≥ 6, brain invasion, sheeting, and adjuvant radiotherapy (RTx) were associated with progression. RTx improved PFS in the subtotal resection (STR) group but not in the GTR group. Among GTR patients, those with MC ≥ 6 had worse outcomes. Conclusion: GTR and RTx may reduce the progression of AM. MC ≥ 6 significantly increases the risk of progression, even in GTR patients. RTx should be considered for all STR patients A more vigilant follow-up or consideration of RTx is warranted in GTR patients when a high MC is identified.
- Open Access
- 28 November 2025
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 13 (6) , e70192
Unbiased microRNA –Disease Association Prediction Using ICD ‐11 Codes and Negative Sampling
We developed a computational model, called “Unbiased microRNA–disease association predictor (UBMDA),” to predict microRNA–disease associations. UBMDA has two major differences from those reported previously. First, we did not apply a similarity‐based feature extraction method, which is the main basis of previous studies. Instead, we used International Classification of Diseases 11th Revision disease codes and microRNA nucleotide sequences as input features. Thus, UBMDA can be applied to newly discovered or poorly studied microRNAs and diseases. Second, we constructed an appropriate negative sample dataset. A positive sample dataset consisting of microRNAs and diseases pairs with proven associations between microRNAs and diseases is publicly available. However, datasets reporting no associations between microRNAs and diseases are rare. Therefore, a negative sample dataset was created by combining microRNAs and diseases. Because more commonly studied microRNAs and diseases are more likely to be included in the positive sample dataset, creating a negative sample dataset without taking this bias into consideration could cause an imbalance in disease and microRNA frequencies between positive and negative sample datasets, leading to biased prediction. To prevent such an imbalance, we created a negative sample dataset considering the frequency of each microRNA and disease in the positive sample dataset, such that these frequencies were similar between the negative and positive sample datasets. We successfully developed a computational model with a simple and intuitive structure. UBMDA will contribute to accelerating the development of microRNA‐related biomarkers and therapeutics.
- 28 November 2025
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 13 (6) , e70192
Open AccessUnbiased microRNA –Disease Association Prediction Using ICD ‐11 Codes and Negative Sampling
We developed a computational model, called “Unbiased microRNA–disease association predictor (UBMDA),” to predict microRNA–disease associations. UBMDA has two major differences from those reported previously. First, we did not apply a similarity‐based feature extraction method, which is the main basis of previous studies. Instead, we used International Classification of Diseases 11th Revision disease codes and microRNA nucleotide sequences as input features. Thus, UBMDA can be applied to newly discovered or poorly studied microRNAs and diseases. Second, we constructed an appropriate negative sample dataset. A positive sample dataset consisting of microRNAs and diseases pairs with proven associations between microRNAs and diseases is publicly available. However, datasets reporting no associations between microRNAs and diseases are rare. Therefore, a negative sample dataset was created by combining microRNAs and diseases. Because more commonly studied microRNAs and diseases are more likely to be included in the positive sample dataset, creating a negative sample dataset without taking this bias into consideration could cause an imbalance in disease and microRNA frequencies between positive and negative sample datasets, leading to biased prediction. To prevent such an imbalance, we created a negative sample dataset considering the frequency of each microRNA and disease in the positive sample dataset, such that these frequencies were similar between the negative and positive sample datasets. We successfully developed a computational model with a simple and intuitive structure. UBMDA will contribute to accelerating the development of microRNA‐related biomarkers and therapeutics.
- Open Access
- 23 July 2025
- Published by Elsevier in World Neurosurgery
- p. 124300
Developing deep learning-based cerebral ventricle auto-segmentation system and clinical application for the evaluation of ventriculomegaly
- 23 July 2025
- Published by Elsevier in World Neurosurgery
- p. 124300
Open AccessDeveloping deep learning-based cerebral ventricle auto-segmentation system and clinical application for the evaluation of ventriculomegaly
- Open Access
- 4 November 2024
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (2) , 137-149
Envisioning the Future of the Neurosurgical Operating Room with the Concept of the Medical Metaverse
The medical metaverse can be defined as a virtual spatiotemporal framework wherein higher-dimensional medical information is generated, exchanged, and utilized through communication among medical personnel or patients. This occurs through the integration of cutting-edge technologies such as augmented reality (AR), virtual reality (VR), artificial intelligence (AI), big data, cloud computing, and others. We can envision a future neurosurgical operating room that utilizes such medical metaverse concept such as shared extended reality (AR/VR) of surgical field, AI-powered intraoperative neurophysiological monitoring, and real-time intraoperative tissue diagnosis. The future neurosurgical operation room will evolve into a true medical metaverse where participants of surgery can communicate in overlapping virtual layers of surgery, monitoring, and diagnosis.
- 4 November 2024
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (2) , 137-149
Open AccessEnvisioning the Future of the Neurosurgical Operating Room with the Concept of the Medical Metaverse
The medical metaverse can be defined as a virtual spatiotemporal framework wherein higher-dimensional medical information is generated, exchanged, and utilized through communication among medical personnel or patients. This occurs through the integration of cutting-edge technologies such as augmented reality (AR), virtual reality (VR), artificial intelligence (AI), big data, cloud computing, and others. We can envision a future neurosurgical operating room that utilizes such medical metaverse concept such as shared extended reality (AR/VR) of surgical field, AI-powered intraoperative neurophysiological monitoring, and real-time intraoperative tissue diagnosis. The future neurosurgical operation room will evolve into a true medical metaverse where participants of surgery can communicate in overlapping virtual layers of surgery, monitoring, and diagnosis.